Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of delirium in acute stroke patients: a position paper by the Austrian Stroke Society on prevention, diagnosis, and treatment.
Kneihsl M, Berger N, Sumerauer S, Asenbaum-Nan S, Höger FS, Gattringer T, Enzinger C, Aigner M, Ferrari J, Lang W. Kneihsl M, et al. Among authors: aigner m. Ther Adv Neurol Disord. 2024 Aug 19;17:17562864241258788. doi: 10.1177/17562864241258788. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 39161955 Free PMC article. Review.
Treatment of CNS systemic lupus erythematosus with CD19 CAR T cells.
Hagen M, Müller F, Wirsching A, Kharboutli S, Spörl S, Aigner M, Völkl S, Köhler B, Dörfler A, Grieshaber-Bouyer R, Mackensen A, Schett G. Hagen M, et al. Among authors: aigner m. Lancet. 2024 Nov 30;404(10468):2158-2160. doi: 10.1016/S0140-6736(24)02265-7. Lancet. 2024. PMID: 39615991 No abstract available.
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series.
Auth J, Müller F, Völkl S, Bayerl N, Distler JHW, Tur C, Raimondo MG, Chenguiti Fakhouri S, Atzinger A, Coppers B, Eckstein M, Liphardt AM, Bäuerle T, Tascilar K, Aigner M, Kretschmann S, Wirsching A, Taubmann J, Hagen M, Györfi AH, Kharboutli S, Krickau T, Dees C, Spörl S, Rothe T, Harrer T, Bozec A, Grieshaber-Bouyer R, Fuchs F, Kuwert T, Berking C, Horch RE, Uder M, Mackensen A, Schett G, Bergmann C. Auth J, et al. Among authors: aigner m. Lancet Rheumatol. 2024 Nov 11:S2665-9913(24)00282-0. doi: 10.1016/S2665-9913(24)00282-0. Online ahead of print. Lancet Rheumatol. 2024. PMID: 39542003 Free article.
Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers.
Fischer-Riepe L, Kailayangiri S, Zimmermann K, Pfeifer R, Aigner M, Altvater B, Kretschmann S, Völkl S, Hartley J, Dreger C, Petry K, Bosio A, von Döllen A, Hartmann W, Lode H, Görlich D, Mackensen A, Jungblut M, Schambach A, Abken H, Rossig C. Fischer-Riepe L, et al. Among authors: aigner m. Clin Cancer Res. 2024 Aug 15;30(16):3564-3577. doi: 10.1158/1078-0432.CCR-23-3157. Clin Cancer Res. 2024. PMID: 38593230
Fully Human Anti-CD19 CAR T Cells Derived from Systemic Lupus Erythematosus Patients Exhibit Cytotoxicity with Reduced Inflammatory Cytokine Production.
Dingfelder J, Aigner M, Taubmann J, Minopoulou I, Park S, Kaplan CD, Cheng JK, Van Blarcom T, Schett G, Mackensen A, Lutzny-Geier G. Dingfelder J, et al. Among authors: aigner m. Transplant Cell Ther. 2024 Jun;30(6):582.e1-582.e10. doi: 10.1016/j.jtct.2024.03.023. Epub 2024 Mar 26. Transplant Cell Ther. 2024. PMID: 38548226 Free article.
202 results